McIlrath & Eck’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
McIlrath & Eck's ACLS Position: Q1 2026 in Review
McIlrath & Eck held its Axcelis (ACLS) position steady in Q1 2026 at 32 shares worth $2.98K. The position accounts for ﹤0.01% of the portfolio, ranked #1343.
McIlrath & Eck first reported a position in ACLS in Q2 2023 and has held it in 12 quarters since. The position peaked at $10.6K in Q2 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- McIlrath & Eck held 32 shares of Axcelis worth $2.98K as of Q1 2026.
- McIlrath & Eck left its Axcelis share count unchanged in Q1 2026.
- Axcelis made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1343 holding.
- McIlrath & Eck first reported a position in Axcelis in Q2 2023 and has held it in 12 quarters since.
- McIlrath & Eck's Axcelis position peaked at $10.6K in Q2 2023.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.